Selective loss of cerebral cortical Sigma, but not PCP binding sites in schizophrenia (Q67913940)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1848113%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

title

Selective loss of cerebral cortical sigma, but not PCP binding sites in schizophrenia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1848113%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

Selective loss of cerebral cortical Sigma, but not PCP binding sites in schizophrenia (English)

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90209-5

8 December 2022

1 reference

A. D. Weissman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1848113

8 December 2022

M. F. Casanova

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1848113

8 December 2022

J. E. Kleinman

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1848113

8 December 2022

E. D. London

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1848113

8 December 2022

E. B. De Souza

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1848113

8 December 2022

language of work or name

English

0 references

publication date

1 January 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1848113%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

19 September 2019

https://api.elsevier.com/content/article/PII:0006322391902095?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90209-5

https://api.elsevier.com/content/article/PII:0006322391902095?httpAccept=text/plain

8 December 2022

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90209-5

8 December 2022

published in

Biological Psychiatry

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1848113%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1848113%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1848113%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

page(s)

41-54

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1848113%20AND%20SRC:MED&resulttype=core&format=json

Phencyclidine-induced psychosis

19 September 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90209-5

Regulation of sigma-receptors: high- and low-affinity agonist states, GTP shifts, and up-regulation by rimcazole and 1,3-Di(2-tolyl)guanidine

8 December 2022

2

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90209-5

Respiratory and subjective effects of dand l-pentazocine.

8 December 2022

4

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90209-5

Basal ganglia and limbic system pathology in schizophrenia. A morphometric study of brain volume and shrinkage.

8 December 2022

5

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90209-5

Sigma receptors negatively modulate agonist-stimulated phosphoinositide metabolism in rat brain

8 December 2022

6

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90209-5

Postmortem evidence of structural brain changes in schizophrenia. Differences in brain weight, temporal horn area, and parahippocampal gyrus compared with affective disorder

8 December 2022

7

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90209-5

Chronic haloperidol treatment up-regulates rat brain PCP receptors

8 December 2022

9

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90209-5

Activation of the A10 mesolimbic system by the sigma-receptor agonist (+)SKF 10,047 can be blocked by rimcazole, a novel putative antipsychotic

8 December 2022

10

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90209-5

Characterization of L-glutamate action on the release of endogenous dopamine from the rat caudate-putamen

8 December 2022

11

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90209-5

An endogenous ligand for the sigma opioid binding site

8 December 2022

12

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90209-5

Autoradiographic distribution of non-dopaminergic binding sites labeled by [3H]haloperidol in rat brain

8 December 2022

13

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90209-5

The effects of phencyclidine and N-allylnormetazocine on midbrain dopamine neuronal activity

8 December 2022

15

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90209-5

Autoradiographic localization of sigma receptor binding sites in guinea pig and rat central nervous system with (+)3H-3-(3-hydroxyphenyl)-N-(1-propyl)piperidine

8 December 2022

16

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90209-5

Subjective effects of narcotic antagonists cyclazocine and nalorphine on the Addiction Research Center Inventory (ARCI)

8 December 2022

17

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90209-5

Gross Pathology of the Cerebellum in Patients Diagnosed and Treated as Functional Psychiatric Disorders

8 December 2022

18

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90209-5

Differential regulation of sigma and PCP receptors after chronic administration of haloperidol and phencyclidine in mice

8 December 2022

19

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90209-5

Prenatal developmental disturbances in the limbic allocortex in schizophrenics

8 December 2022

20

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90209-5

(3H]MK-801 binding sites in postmortem brain regions of schizophrenic patients

8 December 2022

24

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90209-5

Novel antipsychotic drugs share high affinity for sigma receptors

8 December 2022

26

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90209-5

Protein measurement with the Folin phenol reagent

8 December 2022

28

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90209-5

Clinical management of the phencyclidine psychosis

8 December 2022

30

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90209-5

High correlation between the localization of [3H]TCP binding and NMDA receptors.

8 December 2022

31

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90209-5

LIGAND: A versatile computerized approach for characterization of ligand-binding systems

8 December 2022

33

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90209-5

A postmortem study of the effect of chronic opiate abuse on psychotomimetic binding sites of human frontal cortex

8 December 2022

35

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90209-5

Dopamine receptors and the dopamine hypothesis of schizophrenia

8 December 2022

36

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90209-5

Characterization of specific sigma opiate/phencyclidine (PCP)-binding sites in the human brain.

8 December 2022

37

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90209-5

Cerebellar pathology in schizophrenia--cause or consequence?

8 December 2022

38

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90209-5

Selective sigma receptor agonist and antagonist affect dopamine neuronal activity

8 December 2022

39

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90209-5

An anatomy of schizophrenia?

8 December 2022

40

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90209-5

Endogenous ligands for sigma opioid receptors in the brain ("sigmaphin"): evidence from binding assays

8 December 2022

42

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90209-5

Sigma and PCP receptors in human frontal cortex membranes

8 December 2022

44

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90209-5

[3H]TCP: a new tool with high affinity for the PCP receptor in rat brain.

8 December 2022

45

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90209-5

Phenomenological correlates of metabolic activity in 18 patients with chronic schizophrenia.

8 December 2022

46

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90209-5

Pharmacological characteristics and distributions of sigma- and phencyclidine receptors in the animal kingdom

8 December 2022

47

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90209-5

Evidence for a role of haloperidol-sensitive sigma-'opiate' receptors in the motor effects of antipsychotic drugs

8 December 2022

49

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90209-5

Schizophrenia and the frontal lobe

8 December 2022

51

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90209-5

Alterations in local cerebral glucose utilization induced by phencyclidine.

8 December 2022

52

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90209-5

Schizoaffective psychosis. I. Comparative long-term outcome

8 December 2022

55

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90209-5

8 December 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1848113%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

1 reference